About Me
Luzia Berchtold
Email: luzia [dot] berchtold [at] meduniwien [dot] ac [dot] at
Publications
2025
Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: does time of administration matter?
Marjolein Geurts, Luzia Berchtold, Franz Koenig, Burt Nabors, David A Reardon, Joerg C Tonn, Roger Stupp, Thierry Gorlia, Michael Weller, Matthias Preusser; EORTC Brain Tumor Group
Neuro-Oncology Practice, January 2025
@article{10.1093/nop/npaf006,
author = {Geurts, Marjolein and Berchtold, Luzia and Koenig, Franz and Nabors, Burt and Reardon, David A and Tonn, Joerg C and Stupp, Roger and Gorlia, Thierry and Weller, Michael and Preusser, Matthias and EORTC Brain Tumor Group},
title = {Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: does time of administration matter?}, journal = {Neuro-Oncology Practice},
year = {2025},
issn = {2054-2577},
doi = {10.1093/nop/npaf006},
url = {https://doi.org/10.1093/nop/npaf006},
eprint = {https://academic.oup.com/nop/advance-article-pdf/doi/10.1093/nop/npaf006/61488130/npaf006.pdf}
}
author = {Geurts, Marjolein and Berchtold, Luzia and Koenig, Franz and Nabors, Burt and Reardon, David A and Tonn, Joerg C and Stupp, Roger and Gorlia, Thierry and Weller, Michael and Preusser, Matthias and EORTC Brain Tumor Group},
title = {Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: does time of administration matter?}, journal = {Neuro-Oncology Practice},
year = {2025},
issn = {2054-2577},
doi = {10.1093/nop/npaf006},
url = {https://doi.org/10.1093/nop/npaf006},
eprint = {https://academic.oup.com/nop/advance-article-pdf/doi/10.1093/nop/npaf006/61488130/npaf006.pdf}
}
Title
Authors
Journal, Year